Brown Capital Management LLC Sells 392,478 Shares of Inogen, Inc. (NASDAQ:INGN)

Brown Capital Management LLC cut its holdings in Inogen, Inc. (NASDAQ:INGN) by 20.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,558,458 shares of the medical technology company’s stock after selling 392,478 shares during the quarter. Brown Capital Management LLC owned 0.07% of Inogen worth $15,117,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in INGN. Price T Rowe Associates Inc. MD lifted its holdings in shares of Inogen by 5.2% during the first quarter. Price T Rowe Associates Inc. MD now owns 23,868 shares of the medical technology company’s stock valued at $193,000 after purchasing an additional 1,188 shares in the last quarter. Meeder Asset Management Inc. bought a new stake in shares of Inogen in the second quarter worth approximately $30,000. CWM LLC raised its holdings in shares of Inogen by 2,185.9% during the second quarter. CWM LLC now owns 6,629 shares of the medical technology company’s stock valued at $54,000 after purchasing an additional 6,339 shares during the last quarter. Meros Investment Management LP boosted its holdings in Inogen by 1.6% in the second quarter. Meros Investment Management LP now owns 397,209 shares of the medical technology company’s stock worth $3,229,000 after purchasing an additional 6,385 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in Inogen by 8.1% in the second quarter. Bank of New York Mellon Corp now owns 97,132 shares of the medical technology company’s stock worth $790,000 after purchasing an additional 7,240 shares during the last quarter. 89.94% of the stock is currently owned by hedge funds and other institutional investors.

Inogen Price Performance

Shares of NASDAQ:INGN opened at $9.46 on Thursday. The company has a market capitalization of $225.34 million, a P/E ratio of -4.20 and a beta of 1.04. Inogen, Inc. has a 1-year low of $4.93 and a 1-year high of $13.33. The firm’s 50 day simple moving average is $9.74 and its two-hundred day simple moving average is $9.59.

Wall Street Analysts Forecast Growth

INGN has been the topic of several research analyst reports. Needham & Company LLC reissued a “hold” rating on shares of Inogen in a report on Friday, November 8th. StockNews.com raised Inogen from a “hold” rating to a “buy” rating in a research report on Tuesday, November 12th.

Inogen Company Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.